A majority of U.S. surgeons, including those who treat heart patients on a daily basis, say their operating rooms use outdated technology. It is having a negative impact on patient care. 

Individuals with underlying heart disease may want to avoid energy drinks going forward, according to a new Mayo Clinic analysis.

The new-look diet was linked to significant weight loss and reductions in HbA1C levels. Researchers see it as a potential alternative to immediately putting patients on new medications. 

Interventional cardiologist Peter Monteleone, MD, discussed the primary tools used to treat pulmonary embolism in the cath lab.

Teva Pharmaceuticals has officially launched generic liraglutide injections in the United States. Novo Nordisk currently sells liraglutide under the brand name Victoza.

Based on positive results from two different trials, Eli Lilly and Company hopes to secure a new FDA approval for tirzepatide in the months ahead.

Grocery stores have started selling more and more plant-based meat alternatives in recent years, and early evidence suggests replacing even some meat with these products may be beneficial. Researchers did note that more studies on this subject are still needed.

The Cordella platform from Endotronix includes an implantable sensor that tracks the patient’s PA pressure and other helpful health data.

Persistent and paroxysmal atrial fibrillation appear to affect short- and long-term TAVR mortality rates in different ways, according to a new study of nearly 3,000 patients. Some trends fade over time, while others remain in place after many years.